Published in J Infect Dis on April 17, 2007
Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol (2010) 2.63
Age-dependent dysregulation of innate immunity. Nat Rev Immunol (2013) 2.44
Aging of the innate immune system. Curr Opin Immunol (2010) 2.43
Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell (2014) 2.23
Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 2.08
Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol (2009) 2.00
The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine (2012) 1.54
Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell (2011) 1.39
Dysregulation of human Toll-like receptor function in aging. Ageing Res Rev (2010) 1.39
Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis (2011) 1.38
NOX enzymes and pulmonary disease. Antioxid Redox Signal (2009) 1.29
Infectious diseases in the nursing home setting: challenges and opportunities for clinical investigation. Clin Infect Dis (2010) 1.10
TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol (2009) 1.08
Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev Vaccines (2012) 1.01
Effect of aging on microRNAs and regulation of pathogen recognition receptors. Curr Opin Immunol (2014) 0.96
Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model. J Virol (2010) 0.95
A systems biology approach to the effect of aging, immunosenescence and vaccine response. Curr Opin Immunol (2014) 0.93
Rapid loss of dendritic cell and monocyte responses to TLR ligands following venipuncture. J Immunol Methods (2008) 0.92
Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors. Aging Cell (2015) 0.92
Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology (2015) 0.88
High-dimensional analysis of the aging immune system: verification of age-associated differences in immune signaling responses in healthy donors. J Transl Med (2014) 0.87
Reduced bioenergetics and toll-like receptor 1 function in human polymorphonuclear leukocytes in aging. Aging (Albany NY) (2014) 0.86
The role of Toll-like receptors in age-associated lung diseases. J Gerontol A Biol Sci Med Sci (2012) 0.83
Vaccination in the elderly. Microb Biotechnol (2011) 0.82
Paradoxical changes in innate immunity in aging: recent progress and new directions. J Leukoc Biol (2015) 0.82
Statistical approaches for analyzing immunologic data of repeated observations: a practical guide. J Immunol Methods (2013) 0.82
NADPH oxidases in lung health and disease. Antioxid Redox Signal (2014) 0.81
A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis (2008) 0.81
Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis (2014) 0.81
Aging of the human innate immune system in HIV infection. Curr Opin Immunol (2014) 0.81
Aging-dependent alterations in gene expression and a mitochondrial signature of responsiveness to human influenza vaccination. Aging (Albany NY) (2015) 0.81
Aging of the immune system: Focus on inflammation and vaccination. Eur J Immunol (2016) 0.80
Immunosenescence, aging, and systemic lupus erythematous. Autoimmune Dis (2013) 0.80
Aging, cytomegalovirus (CMV) and influenza vaccine responses. Hum Vaccin Immunother (2016) 0.79
Pandemic influenza H1N1 2009, innate immunity, and the impact of immunosenescence on influenza vaccine. Yale J Biol Med (2009) 0.79
Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections. J Gerontol A Biol Sci Med Sci (2016) 0.78
Better immunity in later life: a position paper. Age (Dordr) (2014) 0.77
Immune Responses to Influenza Virus and Its Correlation to Age and Inherited Factors. Front Microbiol (2016) 0.75
Age, serum 25-hydroxyvitamin D and vitamin D receptor (VDR) expression and function in peripheral blood mononuclear cells. Oncotarget (2016) 0.75
The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults. Immunology (2016) 0.75
Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection. Front Immunol (2017) 0.75
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32
Innate immune recognition. Annu Rev Immunol (2001) 26.65
Toll-like receptor control of the adaptive immune responses. Nat Immunol (2004) 19.15
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science (2003) 14.04
Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity (2006) 10.61
Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell (2008) 9.59
Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med (2005) 8.49
Regulation of adaptive immunity by the innate immune system. Science (2010) 8.00
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol (2008) 7.87
Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature (2007) 7.34
Type I interferons in host defense. Immunity (2006) 7.32
Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med (2003) 7.26
IRAK-M is a negative regulator of Toll-like receptor signaling. Cell (2002) 6.79
Regulation of phagosome maturation by signals from toll-like receptors. Science (2004) 6.79
A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol (2008) 6.78
Control of inducible gene expression by signal-dependent transcriptional elongation. Cell (2009) 6.57
Control of B-cell responses by Toll-like receptors. Nature (2005) 6.44
Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell (2006) 6.01
RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature (2002) 5.95
Toll-like receptor signaling pathways. Science (2003) 5.86
Trajectories of disability in the last year of life. N Engl J Med (2010) 5.55
Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science (2007) 5.54
Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature (2006) 5.54
Serum antibody responses after intradermal vaccination against influenza. N Engl J Med (2004) 4.88
Transitions between frailty states among community-living older persons. Arch Intern Med (2006) 4.38
Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol (2005) 4.30
Toll-like receptors and cancer. Nat Rev Cancer (2008) 4.29
The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature (2002) 4.15
Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity (2006) 3.98
Pattern recognition receptors and control of adaptive immunity. Immunol Rev (2009) 3.91
Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med (2002) 3.86
Hospitalization, restricted activity, and the development of disability among older persons. JAMA (2004) 3.85
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis (2005) 3.79
Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol (2009) 3.79
MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab (2009) 3.64
Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol (2003) 3.18
Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J Immunol (2002) 3.12
On regulation of phagosome maturation and antigen presentation. Nat Immunol (2006) 3.11
Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A (2012) 2.96
Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology (2011) 2.90
Toll-dependent control mechanisms of CD4 T cell activation. Immunity (2004) 2.88
Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol (2005) 2.85
A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe (2010) 2.84
Effect of dissemination of evidence in reducing injuries from falls. N Engl J Med (2008) 2.81
Change in disability after hospitalization or restricted activity in older persons. JAMA (2010) 2.80
Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med (2002) 2.77
Bathing disability and the risk of long-term admission to a nursing home. J Gerontol A Biol Sci Med Sci (2006) 2.73
p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell (2010) 2.65
Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol (2010) 2.63
Dose-related effects of smallpox vaccine. N Engl J Med (2002) 2.55
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis (2012) 2.55
Retroviral delivery of small interfering RNA into primary cells. Proc Natl Acad Sci U S A (2002) 2.43
Toll-like receptors: linking innate and adaptive immunity. Microbes Infect (2004) 2.38
Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol (2005) 2.30
Risk factors and precipitants of long-term disability in community mobility: a cohort study of older persons. Ann Intern Med (2012) 2.27
The immunogenetics of smallpox vaccination. J Infect Dis (2007) 2.23
Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science (2013) 2.22
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A (2014) 2.22
Age-associated defect in human TLR-1/2 function. J Immunol (2007) 2.20
The dynamic nature of mobility disability in older persons. J Am Geriatr Soc (2006) 2.14
Restricting symptoms in the last year of life: a prospective cohort study. JAMA Intern Med (2013) 2.13
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat Immunol (2007) 2.11
Triggering TLR signaling in vaccination. Trends Immunol (2005) 2.09
Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis (2004) 2.06
Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol (2009) 2.00
Allergic host defences. Nature (2012) 1.99
The epidemiology of bathing disability in older persons. J Am Geriatr Soc (2006) 1.97
Serum micronutrient concentrations and decline in physical function among older persons. JAMA (2008) 1.96
Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol (2002) 1.92
Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest (2010) 1.90
Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity (2013) 1.88
Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity (2013) 1.88
Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions. J Infect Dis (2005) 1.84
Gene-specific control of the TLR-induced inflammatory response. Clin Immunol (2008) 1.80
Toll-like receptors and acquired immunity. Semin Immunol (2004) 1.79
Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. J Am Geriatr Soc (2008) 1.79
Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J Virol (2007) 1.77
Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis (2011) 1.71
Geriatric impairments and disability: the cardiovascular health study. J Am Geriatr Soc (2010) 1.69
Subtypes of disability in older persons over the course of nearly 8 years. J Am Geriatr Soc (2008) 1.69
The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Vaccine (2007) 1.68
Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge. Vaccine (2007) 1.67
Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. J Clin Microbiol (2003) 1.63
Innate control of adaptive immunity via remodeling of lymph node feed arteriole. Proc Natl Acad Sci U S A (2005) 1.62
Innate immunity--cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr Opin Immunol (2006) 1.62
Pilot testing of intervention protocols to prevent pneumonia in nursing home residents. J Am Geriatr Soc (2009) 1.60